S&P 500   4,966.57 (-0.89%)
DOW   37,949.61 (+0.46%)
QQQ   414.40 (-2.13%)
AAPL   165.07 (-1.18%)
MSFT   399.32 (-1.22%)
META   481.12 (-4.12%)
GOOGL   153.90 (-1.35%)
AMZN   174.24 (-2.78%)
TSLA   146.99 (-1.96%)
NVDA   769.04 (-9.17%)
AMD   146.04 (-5.83%)
NIO   3.81 (-4.75%)
BABA   69.08 (+0.29%)
T   16.48 (+0.92%)
F   12.09 (+0.25%)
MU   106.18 (-5.14%)
GE   148.36 (-2.99%)
CGC   7.99 (+2.04%)
DIS   112.17 (-0.23%)
AMC   3.21 (+9.93%)
PFE   25.96 (+2.24%)
PYPL   61.86 (-0.39%)
XOM   119.87 (+1.14%)
S&P 500   4,966.57 (-0.89%)
DOW   37,949.61 (+0.46%)
QQQ   414.40 (-2.13%)
AAPL   165.07 (-1.18%)
MSFT   399.32 (-1.22%)
META   481.12 (-4.12%)
GOOGL   153.90 (-1.35%)
AMZN   174.24 (-2.78%)
TSLA   146.99 (-1.96%)
NVDA   769.04 (-9.17%)
AMD   146.04 (-5.83%)
NIO   3.81 (-4.75%)
BABA   69.08 (+0.29%)
T   16.48 (+0.92%)
F   12.09 (+0.25%)
MU   106.18 (-5.14%)
GE   148.36 (-2.99%)
CGC   7.99 (+2.04%)
DIS   112.17 (-0.23%)
AMC   3.21 (+9.93%)
PFE   25.96 (+2.24%)
PYPL   61.86 (-0.39%)
XOM   119.87 (+1.14%)
S&P 500   4,966.57 (-0.89%)
DOW   37,949.61 (+0.46%)
QQQ   414.40 (-2.13%)
AAPL   165.07 (-1.18%)
MSFT   399.32 (-1.22%)
META   481.12 (-4.12%)
GOOGL   153.90 (-1.35%)
AMZN   174.24 (-2.78%)
TSLA   146.99 (-1.96%)
NVDA   769.04 (-9.17%)
AMD   146.04 (-5.83%)
NIO   3.81 (-4.75%)
BABA   69.08 (+0.29%)
T   16.48 (+0.92%)
F   12.09 (+0.25%)
MU   106.18 (-5.14%)
GE   148.36 (-2.99%)
CGC   7.99 (+2.04%)
DIS   112.17 (-0.23%)
AMC   3.21 (+9.93%)
PFE   25.96 (+2.24%)
PYPL   61.86 (-0.39%)
XOM   119.87 (+1.14%)
S&P 500   4,966.57 (-0.89%)
DOW   37,949.61 (+0.46%)
QQQ   414.40 (-2.13%)
AAPL   165.07 (-1.18%)
MSFT   399.32 (-1.22%)
META   481.12 (-4.12%)
GOOGL   153.90 (-1.35%)
AMZN   174.24 (-2.78%)
TSLA   146.99 (-1.96%)
NVDA   769.04 (-9.17%)
AMD   146.04 (-5.83%)
NIO   3.81 (-4.75%)
BABA   69.08 (+0.29%)
T   16.48 (+0.92%)
F   12.09 (+0.25%)
MU   106.18 (-5.14%)
GE   148.36 (-2.99%)
CGC   7.99 (+2.04%)
DIS   112.17 (-0.23%)
AMC   3.21 (+9.93%)
PFE   25.96 (+2.24%)
PYPL   61.86 (-0.39%)
XOM   119.87 (+1.14%)
Free Trial
ASX:DXB

Dimerix (DXB) Stock Price, News & Analysis

→ This company has increased its dividend every year for 54 years (From DTI) (Ad)
Free DXB Stock Alerts
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
5.16%
Price Target
N/A
Stock Analysis
Stock Analysis

About Dimerix

Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs. It develops DMX-200, a Phase 3 clinical trial for focal segmental glomerulosclerosis disease; DMX-200 for diabetic kidney disease; and DMX-700 for chronic obstructive pulmonary disease, as well as develops proprietary receptor- HIT assay technology. The company is headquartered in Fitzroy, Australia.

DXB Stock News Headlines

April 16, 2024 | afr.com
Dimerix Limited
April 8, 2024 | finance.yahoo.com
Companies Like Dimerix (ASX:DXB) Could Be Quite Risky
April 19, 2024 | DTI (Ad)
Here’s how to start a “Weekend Side Hustle” from your sofa
Here’s how you can start your very own “Weekend Side Hustle” right from the comfort of your sofa! It doesn't matter if you have a multi-million dollar retirement account… Or if you’re just starting out with a few thousand.
April 8, 2024 | finance.yahoo.com
Investors ignore increasing losses at Dimerix (ASX:DXB) as stock jumps 236% this past week
April 8, 2024 | finance.yahoo.com
Shareholders Will Likely Find Dimerix Limited's (ASX:DXB) CEO Compensation Acceptable
April 8, 2024 | finance.yahoo.com
Calculating The Intrinsic Value Of Dimerix Limited (ASX:DXB)
August 29, 2022 | finance.yahoo.com
Trade Alert: Peter Meurs At Dimerix Limited (ASX:DXB), Has Just Spent AU$3.5m Buying 66% More Shares
August 29, 2022 | finance.yahoo.com
Here's Why We're Watching Dimerix's (ASX:DXB) Cash Burn Situation
April 19, 2024 | DTI (Ad)
With the “Bitcoin Loophole” you can supercharge the gains by 10x or more
Thanks to this newly discovered Bitcoin Loophole, you can now trade Bitcoin in any regular brokerage account… And not only that… you can use it to supercharge the gains of Bitcoin by 10x or more! You see, thanks to one unique investor's brand new discovery - anyone with a regular brokerage account can now tap into the most explosive asset in history. That means you can skip the hassle of opening a Coinbase account… Bypass the fees and hard-to-remember passwords…
August 29, 2022 | finance.yahoo.com
We Think Dimerix (ASX:DXB) Needs To Drive Business Growth Carefully
See More Headlines
Receive DXB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dimerix and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
ASX:DXB
CUSIP
N/A
CIK
N/A
Web
dimerix.com
Phone
1.212.250.8024
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
A($0.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-10,870,000.00
Net Margins
-119.20%
Pretax Margin
N/A
Return on Equity
-330.96%
Return on Assets
-63.63%

Debt

Debt-to-Equity Ratio
83.19
Current Ratio
4.84
Quick Ratio
7.91

Sales & Book Value

Annual Sales
$9.12 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
548,600,000
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
0.51
Ten Starter Stocks For Beginners to Buy Now Cover
Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Dr. Nina Webster B.Sc.
    M.B.A., M.IP.Law, MBA, Ph.D., CEO, MD & Director
  • Mr. Hamish George B.Com.
    C.A., CFO & Company Secretary
  • Dr. David Everett Fuller BPharm (Age 60)
    M.D., MBBS, Chief Medical Officer
  • Mr. Kevin Donald George Pfleger BA (Hons)
    MA, Ph.D., Chief Scientific Advisor
  • Mr. Robert Shepherd
    Chief Commercialisation Officer

Key Competitors

View All Competitors

Insiders


This page (ASX:DXB) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
He Is Giving Away Bitcoin
Crypto Swap Profits
Your Money is Not Safe
American Alternative
The #1 Crypto for 2024
InvestorPlace
SHOCKING Crypto Leak…
Crypto 101 Media
My biggest AI fear
Paradigm Press